ArticleFunctional & integrative genomics2026
Isolation and characterization of Enterococcus phages vB_EfaS_785CC and vB_EfaS_785CS.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Phage therapy offers a promising alternative to antibiotics, with lysin capacity being a key determinant of therapeutic efficacy. This study isolated two Enterococcus faecalis phages, vB_EfaS_785CC and vB_EfaS_785CS, from aquatic market sewage. They are classified as species LY0322 in the genus Efquatrovirus of the class Caudoviricetes, had rapid lysis and potent antibacterial activity against multidrug-resistant enterococci, highlighting their biocontrol potential. Despite a 99.95% nucleotide sequence similarity, these two phages display significant phenotypic differences in lysis ability. Comparative genomic analysis indicates that these lytic differences stem primarily from variable-length homopolymer-tracts in their genomes, which induce coding mutations affecting tail proteins and DNA metabolism genes, thus influencing lysis capacity. The findings guide future research in enhancing phage lytic potential.
Indexed as
Identifiers
42319495What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.